StockData
Septerna, Inc. logo

Septerna, Inc. (SEPN) stock

SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30165% above fair value
$39.45−0.57 (-1.42%)

Close on Nov 18, 2026Market cap $1.84BP/E –Yield –

Septerna revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Septerna's revenue for the twelve months ending Sep 30, 2026 was $96.27M, up 336.7% year over year. For fiscal 2025 it was $45.95M, up 4174.5% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$45.95M+4174.5%
FY2024Dec 31, 2024$1.08M+611.9%
FY2023Dec 31, 2023$151.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$18.88M-12.2%
Q2 FY2026Jun 30, 2026$26.75M+22375.6%
Q1 FY2026Mar 31, 2026$26.52M+12011.0%
Q4 FY2025Dec 31, 2025$24.12M+11276.4%
Q3 FY2025Sep 30, 2025$21.50M+12113.1%
Q2 FY2025Jun 30, 2025$119.00K-67.8%
Q1 FY2025Mar 31, 2025$219.00K-30.9%
Q4 FY2024Dec 31, 2024$212.00K+79.7%
Q3 FY2024Sep 30, 2024$176.00K+433.3%
Q2 FY2024Jun 30, 2024$370.00K–
Q1 FY2024Mar 31, 2024$317.00K–
Q4 FY2023Dec 31, 2023$118.00K–
Q3 FY2023Sep 30, 2023$33.00K–

More Septerna figures

See a number that looks wrong?